Aerosolized Alpha-1 antitrypsin: Interim Phase II/III data

Interim data from a double-blind, placebo-controlled, European Phase II/III trial in patients with emphysema showed that inhaled AAT for 13 months was safe. The product, which uses the eFlow Nebulizer...